Up-to-date news about Intravacc
Stay informed about the latest developments in our mission to pioneer transformative vaccines with up-to-date corporate communications. Get the latest news on our development and business milestones, as well as industry insights, partnership announcements, and corporate reports.
![](/fileadmin/_processed_/9/6/csm_Partner-Chonquing-Zhifei_b70408fbba.jpg)
Enabling Tech Transfer of B. pertussis OMV Technology to our Partner Chonquing Zhifei Biological Products
![press 17 press 17](/fileadmin/_processed_/c/1/csm_press-17_6ca077aac8.jpg)
CEPI partners with Intravacc to develop an intranasal, broadly protective Betacoronavirus vaccinee
![](/fileadmin/_processed_/9/c/csm_Whooping-caugh_Avacc3_465cd51985.jpg)
Intravacc signs an exclusive license agreement with Zhifei Lvzhu Biopharmaceutical to commercialize Avacc 3
![Shigellois Shigellois](/fileadmin/_processed_/0/b/csm_Shigellois_645bb5c73c.jpg)
Intravacc announces the publication of a GMP process for a semi-synthetic Shigella glycoconjugate vaccine candidate from the Institut Pasteur
![partner 4 partner 4](/fileadmin/_processed_/e/1/csm_partner-4_3f268ed177.jpg)
Intravacc and Therapyx jointly develop the world's first prophylactic gonorrhea vaccine